Resverlogix (RVXCF, $0.04) was a top loser over the last three months, falling -1 to $0.04 per share. A.I.dvisor analyzed 861 stocks in the Biotechnology Industry for the 3-month period ending December 13, 2024, and found that of them () exhibited an Uptrend while of them () demonstrated a Downtrend.